This inventor holds 4 USPTO granted patents and 6 published patent applications. Top assignee: The Penn State Research Foundation. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2019
Title: Arun K Sharma: Innovator in Cancer Treatment
Introduction
Arun K Sharma is a notable inventor based in Hummelstown, PA (US), recognized for his contributions to cancer treatment through innovative compounds. With a total of 4 patents, he has made significant strides in the field of medical research.
Latest Patents
Among his latest patents are the "Selenazolidine and thiazolidine compounds for treating cancer and other diseases." This invention includes compounds that are useful in preventing or treating cancer in subjects in need. The methods described involve administering a therapeutically effective amount of these compounds to achieve desired health outcomes. Another significant patent is for "Anti-cancer compositions and methods," which details compositions that include isothiocyanates and/or isoselenocyanates. These methods aim to treat conditions characterized by Akt dysregulation, enhancing apoptosis and reducing the proliferation of cancer cells.
Career Highlights
Arun K Sharma is affiliated with the Penn State Research Foundation, where he continues to advance his research in cancer therapies. His work is characterized by a commitment to developing effective treatments that can significantly impact patient care.
Collaborations
He collaborates with esteemed colleagues such as Shantu G Amin and Gavin P Robertson, contributing to a dynamic research environment focused on innovative solutions for cancer treatment.
Conclusion
Arun K Sharma's work exemplifies the intersection of innovation and healthcare, showcasing how dedicated research can lead to breakthroughs in cancer treatment. His contributions are vital in the ongoing fight against cancer, and his patents reflect a commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
